Sparlon Risk Management Plan For Serious Skin Reactions To Be Discussed By Committee
During review, FDA staff disagrees about significance and implications of serious skin reactions and other adverse events with Sparlon.
During review, FDA staff disagrees about significance and implications of serious skin reactions and other adverse events with Sparlon.